Biology of tumor micrometastasis

Journal of Hematotherapy and Stem Cell Research

Volumn 5, Issue 5, 1996, Pages 525-535

  Ahmad, A ^a   Hart, I R ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC PROTEINASE; CADHERIN; CELL ADHESION MOLECULE; COLLAGENASE; CYSTEINE PROTEINASE; IMMUNOGLOBULIN; INTEGRIN; METALLOPROTEINASE; SCLEROPROTEIN; SELECTIN; SERINE PROTEINASE; STROMELYSIN;

ANGIOGENESIS; BASEMENT MEMBRANE; CANCER INVASION; CELL ADHESION; CELL COMMUNICATION; EXTRACELLULAR MATRIX; MALIGNANT TRANSFORMATION; METASTASIS; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; TUMOR VASCULARIZATION;

CELL ADHESION; HUMANS; NEOPLASM METASTASIS; NEOPLASM, RESIDUAL; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 0029954559     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.1.1996.5.525     Document Type: Article

References (129)

1. Fishcer, B. & Fischer, E.R. Interrelationship of hematogenous and lymphatic tumor cell dissemination. Surg. Gynecol. Obstet. 122:791, 1966.
2. Liotta, L.A., Rao, C.N. & Barsky, S.H. Tumor invasion and the extracellular matrix. Lab. Invest. 49:636, 1983.
3. Aresu, O., Nicolo, G., Allerana, G., et al. Invasive activity, spreading on and chemotactic response to laminin are properties of high but not low metastatic mouse osteosarcoma cells. Invasion Metastasis. 11:2, 1991.
4. Yoshinga, I.G., Vin, K.J., Dekker, S.K., et al. Role of α3β1 and α2β1 integrins in melanoma cell migration. Melanoma Res. 3:435, 1993.
5. Juliano, R.L. The role of β1 integrins in tumours. Semin. Cancer Biol. 4:277, 1993.
6. Albelda, S.M. The role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab. Invest. 68:4, 1993.
7. Duffy, M.J. The role of proteolytic enzymes in cancer invasion and metastasis. Clin. Exp. Met. 10:145, 1992
8. Tryggvason, K., Hoyhtya, M. & Salo, T. Proteolytic degradation of extracellular matrix in tumor invasion. Biochim. Biophys. Acta 907:191, 1987.
9. Murphy, G., Reynolds, J.J., & Hembrey, R.M. Metalloproteinases and cancer invasion and metastasis. Int. J. Cancer 44:757, 1989.
10. Timpl, R. Structure and biological activity of basement membane proteins. Eur. J. Biochem. 180:487, 1989.
11. Farquhar, M.G. The glomerular basement membrane: A selective macromolecular filter. In Cell Biology of Extracellular Matrix, ed. Hay, E.D. Plenum, New York, 1981, p. 3335.
12. Brown, P.D. Proteinase inhibition: A new approach to cancer therapy. Cancer Topics 9:100, 1993.
13. Ballin, M., Gomez, D.E., Sinha, C.C., et al. Ras oncogene-mediated induction of a 92-kDa metalloproteinase: Strong correlation with the malignant phenotype. Biochem. Biophys. Res. Commun. 154:832, 1988.
14. Liotta, L.A., Trygavasson, K., Garbisa, S., et al. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature (Lond.) 284:67, 1980.
15. Nakajima, M., Welch, D.R., Belloni, P.N., et al. Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. Cancer Res. 47:4869, 1987.
16. Van der Stappen, J.W.J., Hendriks, T., Wobbes, T. Correlation between collagenolytic activity and grade of histological differentiation in colorectal tumors. Int. J. Cancer 45:1071, 1990.
17. Wirl, G. & Trick, J. Collagenase: A marker enzyme in human bladder cancer. Urol. Res. 7:103, 1979.
18. Kubochi, K., Otani, Y., Maruyama, K., et al. Development of a direct assay for collagenase against type I and type IV collagenases in tissue homogenate and its application to tumor invasion. In Tschesche, H. (ed) Proteinases in inflammation and tumor invasion. Berlin, de Gruyter, 1986, p. 337.
19. D'Errico, A., Garbisa, S., Liotta, L. A., et al. Augmentation of type IV collagenase, laminin receptor and Ki67 proliferation antigen associated with human colon, gastric and breast carcinoma progression. Mod. Pathol. 4:239, 1991.
20. Garbisa, S., Scagliotti, G., Masiero, L., et al. Correlation of serum metalloproteinase levels with lung cancer metastasis and response to therapy. Cancer Res. 52:4548, 1991.
21. Levy, A., Cioce, V., Sobel, M.E., et al. Increased expression of 72 kD type IV collagenase in human colonie adenocarcinoma. Cancer Res. 51:439, 1991.
22. Monteaggudo, C., Merino, M.J., San-Juan, J., et al. Immunohistochemical distribution of type IV collagenase in normal, benign and malignant breast tissue. Am. J. Pathol. 136:585, 1990.
23. Basset, P., Bellocq, J.P., Wolf, C., et al. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature (Lond.) 348:699, 1990.
24. Engel, G., Heselmeyer, K., Auer, G., et al. Correlation between stromelysin 3 mRNA level and outcome of human breast cancer. Int. J. Cancer 58:830, 1993.
25. Sato, H., Takino, T., Okada, Y., et al. A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370:61, 1994.
26. Emmert-Buck, M.R., Roth, M.I., Zhuang, Z., et al. Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples. Am. J. Pathol. 145:1285, 1994.
27. Duffy, M.J. Plasminogen activators and cancer. Blood Coagul. Fibrinolysis. 1:681, 1990.
28. Duffy, M.J. Do proteases play a role in cancer invasion and metastasis? Eur. J. Cancer Clin. Oncol. 23:583, 1987.
29. Woesner, F.J. Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodelling. FASEB J. 5:2145, 1991.
30. DeClerck, Y A. & Imren, S. Protease inhibitors: Role and potential therapeutic use in human cancer. Eur. J. Cancer. 30A:2170, 1994.
31. DeClerck, Y.A., Yean, T.D., Ratzkin, B.J., et al. Inhibition of autoproteolytic activation of interstitial pro-collagenase by recombinant MI/TIMP2. J. Biol. Chem. 266:3893, 1991.
32. Howard, E.W., Bullen, E.C. & Banda, M.J. Regulation of the autoactivation of human 72 kDa pro-gelatinase by TIMP-2. J. Biol. Chem. 266:13064, 1991.
33. Albini, A., Melchiori, A., Santi, L., et al. Tumor cell invasion by TIMP-2. J. Natl. Cancer Inst. 83:775, 1991.
34. De Clerck, Y., Yean, T.D., Chand, D., et al. Inhibition of tumor invasion of smooth muscle cell layers by recombinant MMP inhibitor. Cancer Res. 51:2151, 1991.
35. Schultz, R.M., Silberman, S., Persky, B., et al. Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells. Cancer Res. 48:5539, 1988.
36. Khokha, R., Zimmer, M.J., Graham, S.H., et al. Suppression of invasion by inducible expression of TIMP-1 in B16-F10 melanoma cells. J. Natl. Cancer Inst. 84:1017, 1992.
37. De Clerck, Y.A., Perez, N., Shimoda, H., et al. Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res. 52:701, 1992.
38. Blei, F., Wilson, E.L., Mignatti, P., et al. Mechanism of action of angiostatic steroids; suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis. J. Cell Physiol. 155:568, 1993.
39. Johnson, M.D., Kim, H.R., Chester, L., et al. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase. J. Cell Physiol. 160:194, 1994.
40. Brown, P.D. & Giavazzi, R. Matrix metalloproteinase inhibition: A review of anti-tumor activity. Ann. Oncol. 6:967, 1995.
41. Macauly, V.M., O'Bryne, K.J., Saunders, M.P., et al. Phase I study of batimastat (MMP inhibitor) in patients with malignant pleural effusions. Br. J. Cancer. 71 (Suppl. XXIV):11 (abstract), 1995.
42. Testa, J.E. & Quigley, J.P. The role of uPA in aggressive tumor cell behavior. Cancer Metastases Rev. 9:353, 1990.
43. Miller, L.B. Structure and function of the urokinase receptor. Coagulation Fibrinolysis 4:292, 1993.
44. Ellis, V., Pyke, C., Eriksen, J., et al. The urokinase receptor: Involvement in cell surface proteolysis and cancer invasion. Ann. NY Acad. Sci. 667:13, 1992.
45. Wei, Y., Waltz, D.A., Rao, N., et al. Identification of the urokinase receptor as an adhesion receptor for vitronectin. J. Biol. Chem. 269:32380, 1994.
46. Skriver, L., Larsson, L., Kielberg, V., et al. Immunocytochemical localization of uPA in Lewis lung carcinoma. J. Cell Biol. 99:753, 1984.
47. Grondahl-Hansen, J., Ralfkizr, E., Kirkeby, L.T., et al. Localization of urokinase-type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans. Am. J. Pathol. 138:111, 1991.
48. Pyke, C., Kristensen, P., Ralfkizr, E., et al. uPA is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colonie adenocarcinomas. Am. J. Pathol. 138:1059, 1991.
49. Duffy, M.J., O'Grady, P., Devney, D., et al. uPA, a marker for aggressive breast cancers. Preliminary report. Cancer 62:531, 1988.
50. Grondahl-Hansen, J., Christensen, I.J., Rosenquist, C., et al. High levels of uPA and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis. Cancer Res. 53:2513, 1993.
51. Dufy, M.J., Reilly, D., O'Sullivan, C., et al. uPA a new and independent prognostic marker in breast cancer. Cancer Res. 50:6827, 1990.
52. Quax, P.H.A., Van-Muijen, G.N., Weening-Veerhoef, E.J., et al. Metastatic behavior of human melanoma cell lines in nude mice correlates with uPA and its type I inhibitor and urokinase mediated matrix degradation. J. Cell Biol. 115:191, 1991.
53. Mignatti, P., Tsuboi, R., Robbins, E., et al. In vitro angiogenesis on the human amniotic membrane: Requirement for bFGF-induced proteinases. J. Cell Biol. 108:671, 1989.
54. Sloane, B.F. Cathepsin B and cystatins: Evidence for a role in cancer progression. Semin. Cancer Biol. 1:137, 1990.
55. Sloane, B.F., Rozhin, J., Johnson, K., et al. Cathepsin B: Association with plasma membrane in metastatic tumors. Proc. Natl. Acad. Sci. USA 83:2483, 1986.
56. Hahnel, R., Harvey, J., Robbins, P., et al. Cathepsin D in human breast cancer: Correlation with vascular invasion and other clinical and histopathological characteristics. Anticancer Res. 13:2131, 1993.
57. Johnson, M.D., Torri, J.A., Lippman, M.E., et al. Cathepsin D in invasiveness of human breast cancer cells. Cancer Res. 53:873, 1993.
58. Garcia, M., Dercocq, D., Pujol, P., et al. Overexpression of transfected cathepsin D in transformed cells increases their malignant phenotype and metastatic potency. Oncogene 5:1809, 1990.
59. Sylven, B. Cellular detachment by purified lysosomal cathepsin B. Eur. J. Cancer 4:559, 1968.
60. Ossowski, L., Quigley, J.P. & Reich, E. Plasminogen - A necessary factor for cell migration. In Reich, E., Rifkin, D.B., and Shaw, W., eds. Proteases and biological control. New York, Cold Spring Harbor Laboratory, p. 901, 1975.
61. Day, E.D., Planinsek, J.A. & Pressman, D. Localization of in vivo radioiodinated rat fibrinogen in the Murphy rat lymphosarcoma and in other transplantable rat tumors. J. Natl. Canc Inst. 22:413, 1959.
62. Gudewicz, P.W. & Gilboa, N. Human uPA stimulates chemotaxis of human neutrophils. Biochem. Biophys. Res. Commun. 147:1176, 1987.
63. Franks, L.M. What is cancer? In Introduction to the Cellular and Molecular Biology of Cancer, eds. Franks, L.M. & Teich, N.M. Oxford University Press, Oxford, 1991, p. 1.
64. Van Roy, F. & Mareel, M. Tumor cell invasion: Effects of cell adhesion and motility. Trends Cell Biol 2:163, 1992.
65. Weinstein, R.S., Merk, F.B. & Alroy, J. The structure and function of intercellular junctions in cancer. Adv. Cancer Res. 23:23, 1976.
66. Jounanneau, J., Tucker, G.C., Boyer, B., et al. Epithelial cell plasticity in neoplasia. Cancer Cells 12:525, 1991.
67. Hynes, R.O. & Lander, A.D. Contact and adhesive specifications in the associations, migrations and targeting of cells and axons. Cell 68:303, 1992.
68. Coman, D.R. Decreased mutual adhesiveness, a property of cells from squamous carcinomas. Cancer Res. 20:1202, 1944.
69. Takeichia, M. The cadherins: Cell-cell adhesion molecules controlling animal morphogenesis. Development 102:639, 1988.
70. Cepek, K.L., Shaw, S.K., Parker, C., et al. Adhesion between epithelial cells and T-lymphocytes mediated by E-cadherin and the αEβ7 integrin. Nature 372:190, 1990
71. Ozawa, M., Baribault, H., & Kemler, R. The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. EMBO J. 8:1711, 1989.
72. Takeichi, M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251:1451, 1991.
73. 2+-dependent adhesion molecules. Trends Biochem Sci. 13:75, 1988.
74. Grunwald, G. The structural and functional analysis of cadherin calcium-dependent cell adhesion molecules. Curr. Opin. Cell Biol. 5:797, 1993.
75. Vestweber, D. & Kemler, R. Identification of a putative cell adhesion domain of uvomorulin. EMBO J. 4:3393, 1985.
76. Behrens, J., Birchmeir, W., Goodman, S.L., et al. Dissociation of Madin-Darby canine kidney epithelial cells by the monoclonal antibody anti-arc-1. J. Cell Biol. 101:1307, 1985.
77. Behrens, J., Mareel, M., Van R.F., et al. Dissecting tumor cell invasion: Epithelial cells acquire invasive properties after loss of uvomorulin-mediated cell adhesion. J. Cell Biol. 108:2435, 1989.
78. Behrens, J. The role of cell adhesion molecules in cancer invasion and metastasis. Breast Cancer Res. Treat. 24:175, 1993.
79. Navarro, P., Gomex, M., Pizarro, A., et al. A role for the E-cadherin cell-cell adhesion molecule during tumor progression of mouse epidermal carcinogenesis. J. Cell Biol. 115:517, 1991.
80. Frixen, U.H., Behrens, J., Sachs, M., et al. E-cadherin mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J. Cell Biol. 113:173, 1991.
81. Chen, W. & Obrink, B. Cell-cell contacts mediated by E-cadherin restrict invasive behavior of L-cells. J. Cell Biol. 114:319, 1991.
82. Dorudi, S., Sheffield, J.P., Poulsom, R., et al. E-cadherin expression in colorectal cancer. Am. J. Pathol. 142:981, 1993.
83. Kinsella, A.R., Green, B., Lepts, G.C., et al. The role of cell-cell adhesion molecule E-cadherin in large bowel tumour cell invasion and metastasis. Br. J. Cancer 67:904, 1993.
84. Rasbridge, S.A., Gillett, C.E., Sampson, S.A., et al. E and P cadherin cell adhesion molecule expression in breast carcinoma. J. Pathol. 169:245, 1992.
85. Shiozaku, H., Tahara, H., Oka, H., et al. Expression of E-cadherin adhesion molecules in human cancers. Am. J. Pathol. 139:17, 1991.
86. Tohma, Y., Yamashima, T., Yamashitata, J., et al. Immunohistochemical localization of cell adhesion molecule E-cadherin in human arachnoid villi and meningiomas. Cancer Res. 52:1981, 1992.
87. Umbas, R., Schalken, J. & Aalders, T.W. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res. 52:5104, 1992.
88. Shimoyama, Y., Hirohasi, S., Hirano, S., et al. Cadherin cell adhesion molecules in human epithelial tissues and carcinomas. Cancer Res. 49:2128, 1991.
89. Eidelman, S., Damsky, C.H., Wheelock, M.J., et al. Expression of the cell-cell adhesion glycoprotein cell-CAM 120/80 in normal human tissues and tumors. Am. J. Pathol. 135:101, 1989.
90. Berx, G., Cleton-Jansen, A.M., Nollet, F., et al. E cadherin is a tumor/invasion suppressor gene mutated in human lobular breast cancers. EMBO J. 14:6107, 1995.
91. Pierceall, W.E., Woodard, A.S., Morrow, J.S., et al. Frequent alterations in E-cadherin and alpha- and beta-catenin expression in human breast cancer cell lines. Oncogene 11:1319, 1995.
92. Humphries, M.J. The molecular basis and specificity of integrin-ligand interactions. J. Cell Sci. 97:585, 1990.
93. Albelda, S.M. & Buck, C.A. Integrins and other cell adhesion molecules. FASEB J. 4:2868, 1990.
94. Hynes, R.O. Integrins: Versatility, modulation, and signalling in cell adhesion. Cell 69:11, 1992.
95. Springer, T.A. Adhesion receptors of the immune system. Nature 346:425, 1990.
96. Albelda, S.M. Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab. Invest. 68:4, 1993.
97. Albelda, S.M., Mette, S.A., Elder, D.E., et al. Integrin distribution in malignant melanoma: Association of the β3 subunit with tumor progression. Cancer Res. 50:6757, 1990.
98. Schadendorf, D., Gawlick, C., Haney, U., et al. Tumor progression and metastatic behavior in vivo correlates with integrin expression on melanocytic tumors. J. Pathol. 170:429, 1993.
99. Moretti, S., Martini, L. & Berti, E. Adhesion molecule profile and malignancy of melanocytic lesions. Melanoma Res. 3:235, 1993.
100. Damjanovich, L., Albelda, S.M., Mette, S.A., et al. The distribution of integrin cell adhesion receptors in normal and malignant lung tissue. J. Immunol. 148:1985, 1992.
101. Hall, P.A., Coates, P., Lemoine, N.R., et al. Characterization of integrin chains in normal and neoplastic human pancreas. J. Pathol. 163:307, 1991.
102. Zutter, M.M., Krigman, H.R. & Santoro, S.A. Altered integrin expression in adenocarcinoma of the breast: Analysis by in-situ hybridization. Am. J. Pathol. 142:1439, 1993.
103. Knox, J.D., Cress, A.B., Clark, V., et al. Differential expression of extracellular matrix molecules and the α6 integrins in normal and neoplastic prostate. Am. J. Pathol. 145:167, 1994.
104. Humphries, M.J., Olden, K. & Yamada, K. A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. Science 233:467, 1986.
105. Ruiz, P., Dunon, D., Sonnenberg, A., et al. Suppression of mouse melanoma metastases by EA-1, a monoclonal antibody specific for α6 integrins. Cell Adhesion Commun. 1:67, 1993.
106. Zutter, M.M., Mazoujian, G. & Santoro, S.A. Decreased expression of integrin adhesive protein receptors in adenocarcinoma of the breast. Am. J. Pathol. 137:863, 1990.
107. Varner, J.A., Fisher, M.H. & Juliano, R.L. Ectopic expression of α5β1 integrin suppresses in vitro growth and tumorigenicity of human colon carcinoma cell lines. Molec. Cell Biol. 3:232a, 1992.
108. Brooks, P.C., Stromblad, S., Sanders, L.C., et al. Localization of MMP-2 to the surface of invasive cells by interaction with integrin αvβ3. Cell 79:1157, 1996.
109. Goridis, C. & Brunet, J.F. NCAM: Structural diversity, function, and regulation of expression. Semin. Cell Biol. 3:189, 1992.
110. Holzmann, B., Brocker, E.B. Lehman, J., et al. Tumor progression in human malignant melanoma: Five stages defined by their antigenic phenotypes. Int. J. Cancer 39:466, 1987.
111. Holzmann, B., Lehman, J. & Ziegler-Herdbrook, L. Glycoprotein p3.58, associated with tumor progression in malignant melanoma, is a novel leucocyte activation antigen. Int. J. Cancer 41:542, 1988.
112. Johnson, J.P. Cell adhesion molecules of the immunoglobulin supergene family and their role in malignant transformation and progression to metastatic disease. Cancer Metastases Rev. 10:11, 1991.
113. Altomonte, M., Gloghine, A., Bertola, G., et al. Differential expression of cell adhesion molecules CD54/CD11a and CD58/CD2 on human melanoma cells and functional role in their interaction with cytotoxic cells. Cancer Res. 1:3343, 1993.
114. Pujol, J.L., Simony, J., Demoly, P., et al. Neural cell adhesion molecule and prognosis of surgically resected lung cancer. Am. Rev. Respir. Dis. 148:1071, 1993.
115. Michelides, R., Kwa, B., Springall, D., et al. NCAM and lung cancer. Int. J. Cancer 8(Suppl):34, 1994.
116. Dejana, E., Martin-Padura, I., Larui, D., et al. ELAM-1 dependent adhesion of colon carcinoma cells to vascular endothelium is inhibited by an antibody to Lewis fucosylated type I carbohydrate chain. Lab. Invest. 66:324, 1992.
117. Sakamoto, S., Watanabe, T., Takumaru, T., et al. Expression of Lewis a, b, y, sialy-Lewis, a, χ blood group antigens in human gastric carcinoma and normal gastric tissue. Cancer Res. 49:745, 1989.
118. Nakamari, S., Kameyama, M., Imaoka, S., et al. Increased expression of sialyl-Lewis χ antigen correlates with poor survival in patients with colorectal carcinoma: Clinicopathological and immunohistochemical study. Cancer Res. 53:3632, 1993.
119. Foulds, L. The experimental study of tumor progression. Cancer Res. 14:327, 1964.
120. Jendraschak, E. & Sage, E.H. Regulation of angiogenesis by SPARC and angiostatin: Implications for tumor cell biology. Semin. Cancer Biol. 7:139, 1996.
121. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med. 1:27, 1995.
122. Prehn, R.T. The inhibition of tumor growth by tumor mass. Cancer Res. 51:2, 1991.
123. O'Reilly, M.S., Holmgren, L., Shing, Y., et al. Angiostatin: A novel angiogenesis inhibitor that mediates suppression of metastases by a Lewis lung carcinoma. Cell 79:315, 1994.
124. Weidner, N., Semple, J., Welch, W., et al. Tumor angiogenesis correlates with metastasis in invasive breast carcinoma. N. Engl. J. Med. 324:1, 1991.
125. Macchiarini, P., Fontanini, G., Hardin, M.J., et al. Relation of neovascularization to metastasis of non-small cell lung cancer. Lancet 340:145, 1992.
126. Murphy, A.N., Unsworth, E.J. & Stetler-Stevensen, W.G. TIMP-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. J. Cell. Physiol. 157:351, 1993.
127. Tarabdetti, G., Garosabo, A., Belotti, D., et al. Inhibition of angiogenesis and murine hemangioma growth by barimastat, a synthetic inhibitor of matrix metalloproteinases. J. Natl. Cancer Inst. 87:293, 1995.
128. Ingber, D., Fujota, T., Kishimoto, S., et al. Synthetic analogs of fumagillin that inhibit angiogenesis and suppress tumor growth. Nature 348:55, 1990.
129. Marione, T.E., Gray, G.S., Petro, J., et al. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science 247:77, 1990.